Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
Asian Network for Early Psychosis
first-episode psychosis
medication discontinuation
relapse
remission
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
16
03
2018
revised:
01
09
2018
accepted:
04
11
2018
pubmed:
30
11
2018
medline:
18
2
2020
entrez:
29
11
2018
Statut:
ppublish
Résumé
The study investigated psychiatrists' views towards the issue of medication discontinuation for patients in remission from first-episode psychosis in four countries (Hong Kong, Korea, Singapore and Japan) that are part of the Asian Network for Early Psychosis, focusing on whether the views of these countries differ with one another. A questionnaire was distributed to psychiatrists for completion. The questionnaire contained three sections: direct questions probing at views on medication discontinuation, case vignettes to assess applied decision-making and a checklist of criteria psychiatrists may view as necessary for the patient to satisfy before discontinuation. Total of 484 psychiatrists (97 from Hong Kong, 88 from Korea, 64 from Singapore and 233 from Japan) completed the questionnaire. We found that (a) Asian psychiatrists believed that 1% to 19% of remitted patients can discontinue medication, an estimation that was lower than Western psychiatrists; (b) in agreement with clinical guidelines, Asian psychiatrists believed that patients should remain on medication for at least 1 to 2 years following the absence of psychotic symptoms; (c) "Absence of any relapsing episode following first episode" was considered the most important criterion when making a decision; and (d) there were significant differences in clinicians' perceptions across the four countries: for instance, Korean psychiatrists were more conservative with the duration of antipsychotics maintenance, while Singaporean psychiatrists were more open-minded towards clinical trials. Culture and social norms appear to determine the relative importance of factors that psychiatrists might consider during the decision-making process, thereby producing variations in the views held in different countries.
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1329-1337Subventions
Organisme : Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities
Pays : International
Organisme : University Research Committee: Seed Funding for Basic Research for New Staff
ID : 201606159003
Pays : International
Organisme : Japan Agency for Medical Research and Development
Pays : International
Organisme : University Research Committee
ID : 201606159003
Pays : International
Informations de copyright
© 2018 John Wiley & Sons Australia, Ltd.
Références
Allison, D. B., Newcomer, J. W., Dunn, A. L., Blumenthal, J. A., Fabricatore, A. N., Daumit, G. L., … Alpert, J. E. (2009). Obesity among those with mental disorders: A National Institute of Mental Health meeting report. American Journal of Preventive Medicine, 36, 341-350. https://doi.org/10.1016/j.amepre.2008.11.020
American Psychiatric Association. (2004). Practice guideline for the treatment of patients with schizophrenia (2nd ed.). Washington, DC: American Psychiatric Association.
Asian Network of Early Psychosis Writing Group. (2012). Early psychosis declaration for Asia by the Asian Network of Early Psychosis. East Asian Archives of Psychiatry, 22, 90-93.
Chen, E. Y., Hui, C. L., Lam, M. M., Chiu, C. P., Law, C. W., Chung, D. W., … Honer, W. G. (2010). Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: Randomised controlled trial. British Medical Journal, 341, c4024. https://doi.org/10.1136/bmj.c4024
Correll, C. U., Leucht, S., & Kane, J. M. (2004). Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies. American Journal of Psychiatry, 161, 414-425. https://doi.org/10.1176/appi.ajp.161.3.414
Fakhoury, W. K., Wright, D., & Wallace, M. (2001). Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. International Clinical Psychopharmacology, 16, 153-162. https://doi.org/10.1097/00004850-200105000-00004
Hui, C., Wong, G., Lam, C., Chow, P., & Chen, E. (2008). Patient-clinician communication and needs identification for outpatients with schizophrenia in Hong Kong: Role of the 2-COM instrument. Hong Kong Journal of Psychiatry, 18, 69-75.
International Early Psychosis Association Writing Group. (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(S48), s120-s124. https://doi.org/10.1192/bjp.187.48.s120
Klein, W. M., & Stefanek, M. E. (2007). Cancer risk elicitation and communication: Lessons from the psychology of risk perception. CA Cancer Journal for Clinicians, 57, 147-167.
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., & Davis, J. M. (2012). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews, 5, CD008016. https://doi.org/10.1002/14651858.CD008016.pub2
Lieberman, J., Jody, D., Geisler, S., Alvir, J., Loebel, A., Szymanski, S., … Borenstein, M. (1993). Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry, 50, 369-376. https://doi.org/10.1001/archpsyc.1993.01820170047006
Lieberman, J. A. (1993). Prediction of outcome in first-episode schizophrenia. Journal of Clinical Psychiatry, 54(suppl), 13-17.
Llorca, P. M. (2008). Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Research, 161, 235-247. https://doi.org/10.1016/j.psychres.2007.07.012
Masand, P. S., Roca, M., Turner, M. S., & Kane, J. M. (2009). Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: A review. Primary Care Companion to The Journal of Clinical Psychiatry, 11, 147-154. https://doi.org/10.4088/PCC.08r00612
McGorry, P. (2012). Early intervention for psychosis in Asia. East Asian Archives of Psychiatry, 22, 88-89.
Moncrieff, J., & Leo, J. (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine, 40, 1409-1422. https://doi.org/10.1017/S0033291709992297
National Institute for Health and Care Excellence. (2014). Psychosis and schizophrenia in adults: Treatment and Management. National Clinical Guideline Number 178. London, England: NICE.
Nederhof, A. J. (1985). Methods of coping with social desirability bias: A review. European Journal of Social Psychology, 15, 263-280. https://doi.org/10.1002/ejsp.2420150303
Power, P., Elkins, K., Adlard, S., Curry, C., McGorry, P., & Harrigan, S. (1998). Analysis of the initial treatment phase in first-episode psychosis. British Journal of Psychiatry, 172(S33), s71-s76.
Robinson, D., Woerner, M. G., Alvir, J. M., Bilder, R., Goldman, R., Geisler, S., … Lieberman, J. A. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-247. https://doi.org/10.1001/archpsyc.56.3.241
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. (2005). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 39, 1-30. https://doi.org/10.1177/0004867416641195
Thompson, A., Singh, S., & Birchwood, M. (2015). Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis. Early Intervention in Psychiatry, 10, 355-361. https://doi.org/10.1111/eip.12244
Usher, K. (2001). Taking neuroleptic medications as the treatment for schizophrenia: A phenomenological study. Australian and New Zealand Journal of Mental Health Nursing, 10, 145-155. https://doi.org/10.1046/j.1440-0979.2001.00205.x
Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998). Natural course of schizophrenic disorders: A 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bulletin, 24, 75-85. https://doi.org/10.1093/oxfordjournals.schbul.a033315
Williams, K., & Pinfold, V. (2006). Side effects: Mental health service users' experiences of the side effects of antipsychotic medication. London, England: Rethink Publications.
Zipursky, R. B., Menezes, N. M., & Streiner, D. L. (2014). Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review. Schizophrenia Research, 152, 408-414. https://doi.org/10.1016/j.schres.2013.08.001